Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents

Summary

COVID-19 vaccines are available to children over six months, and these vaccines are powerful tools against this catastrophic pandemic. However, Hispanic/Latino children have lower COVID-19 vaccination rates than White non-Hispanic children .Our team of health communication and public health experts proposes a community-based theory-driven intervention that utilizes culturally-grounded narratives from digital storytelling to reduce Hispanic parents' COVID-19 vaccine hesitancy and increase their children's vaccine uptake.

Conditions

• Vaccine-Preventable Diseases
• COVID-19 Pandemic
• Health-Related Behavior
• Health Knowledge, Attitudes, Practice
• Narration

Interventions

BEHAVIORAL

Baseline surveys

Baseline surveys contained a series of scaled questions, including sociodemographic variables (age, gender, income, education level, relationship to the child), parental COVID-19 vaccine hesitancy, intentions to vaccinate child against COVID-19, and parents' attitudes, perceived norms, and perceived behavioral control about vaccinating their child against COVID-19,

BEHAVIORAL

Digital Storytelling Intervention

In Aim 1, the investigators are creating intervention materials for Study Aim 2. These intervention materials include ten digital stories (each 2-3 minutes long) with a diverse sample of Hispanic parents and legal guardians who transformed from being COVID-19 vaccine-hesitant to vaccine-accepting. Each story uses individuals' own brief first-person visual narratives/stories that use digital images, audio recordings, music, and text to document personal experiences.

BEHAVIORAL

Information Control Intervention

The control group participants will receive a CDC COVID-19 vaccine information sheet appropriate for their child's age.

Sponsors & Collaborators

• Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

  collaborator NIH

• Arizona State University

  lead OTHER

Principal Investigators

• Alexis Koskan, Ph.D · Arizona State University

• Sunny W Kim, Ph.D · Arizona State University

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2023-12-01

Primary Completion

2025-08-31

Completion

2025-08-31

Countries

• United States

Study Locations